These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15821837)

  • 1. Trends in the care of patients with acute myocardial infarction at a university-affiliated Veterans Affairs Medical Center.
    Bansal D; Gaddam V; Aude YW; Bissett J; Fahdi I; Garza L; Joseph J; Molavi B; Pai BV; Sinha A; Smith ES; Mehta JL
    J Cardiovasc Pharmacol Ther; 2005 Mar; 10(1):39-44. PubMed ID: 15821837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in long-term management of survivors of acute myocardial infarction by cardiologists in a government university-affiliated teaching hospital.
    Mitra S; Findley K; Frohnapple D; Mehta JL
    Clin Cardiol; 2002 Jan; 25(1):16-8. PubMed ID: 11808833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
    Lee HY; Cooke CE; Robertson TA
    J Manag Care Pharm; 2008 Apr; 14(3):271-80. PubMed ID: 18439049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.
    Barron HV; Michaels AD; Maynard C; Every NR
    J Am Coll Cardiol; 1998 Aug; 32(2):360-7. PubMed ID: 9708461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
    Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
    Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities?
    Petersen LA; Normand SL; Druss BG; Rosenheck RA
    Health Serv Res; 2003 Feb; 38(1 Pt 1):41-63. PubMed ID: 12650380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH; Yang DH; Park HS; Cho Y; Jeong MH; Kim YJ; Kim KS; Hur SH; Seong IW; Hong TJ; Cho MC; Kim CJ; Jun JE; Park WH; Chae SC;
    Am Heart J; 2010 Jun; 159(6):1012-9. PubMed ID: 20569714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U; Jünger C; Zahn R; Bauer T; Bestehorn K; Senges J; Gitt A
    Curr Med Res Opin; 2011 Aug; 27(8):1563-70. PubMed ID: 21682553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program.
    Xie JX; Gunzburger EC; Kaun L; Plomondon ME; Barón AE; Waldo SW; Virani SS; Maddox TM; Mavromatis K
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e005455. PubMed ID: 31665896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of early follow-up after acute myocardial infarction with higher rates of medication use.
    Daugherty SL; Ho PM; Spertus JA; Jones PG; Bach RG; Krumholz HM; Peterson ED; Rumsfeld JS; Masoudi FA
    Arch Intern Med; 2008 Mar; 168(5):485-91; discussion 492. PubMed ID: 18332293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of the relationship between specialist training in cardiology and implementation of evidence-based care of patients following acute myocardial infarction.
    Dorsch MF; Lawrance RA; Sapsford RJ; Durham N; Das R; Jackson BM; Morrell C; Ball SG; Robinson MB; Hall AS;
    Int J Cardiol; 2004 Sep; 96(3):335-40. PubMed ID: 15301884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L; Wallentin L; Stenestrand U; Lappas G; Rosengren A
    Arch Intern Med; 2010 Aug; 170(15):1375-81. PubMed ID: 20696964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction.
    Arnold SV; Spertus JA; Masoudi FA; Daugherty SL; Maddox TM; Li Y; Dodson JA; Chan PS
    J Am Coll Cardiol; 2013 Nov; 62(19):1791-801. PubMed ID: 23973701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping geographic areas of high and low drug adherence in patients prescribed continuing treatment for acute coronary syndrome after discharge.
    Hoang C; Kolenic G; Kline-Rogers E; Eagle KA; Erickson SR
    Pharmacotherapy; 2011 Oct; 31(10):927-33. PubMed ID: 21950639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of combination evidence-based medical therapy prior to acute myocardial infarction (from the National Registry of Myocardial Infarction-4).
    Spencer FA; Frederick PD; Goldberg RJ; Gore JM; Tiefenbrunn AJ;
    Am J Cardiol; 2005 Oct; 96(7):922-6. PubMed ID: 16188517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities in prescriptions for cardioprotective drugs and cardiac outcomes in Veterans Affairs Hospitals.
    Mehta JL; Bursac Z; Mehta P; Bansal D; Fink L; Marsh J; Sukhija R; Sachdeva R
    Am J Cardiol; 2010 Apr; 105(7):1019-23. PubMed ID: 20346324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of use of medications after acute myocardial infarction in the Veterans Health Administration and Medicare.
    Petersen LA; Normand SL; Leape LL; McNeil BJ
    Circulation; 2001 Dec; 104(24):2898-904. PubMed ID: 11739303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.